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Clinimetrics in rehabilitation medicine, i.e. the ﬁeld of
developing, evaluating and applying measurement instru-
ments, has undergone considerable progress. Despite this
progress, however, several issues remain. These include: (i)
selection of an instrument out of the wide range available;
(ii) using an instrument in a variety of diagnostic groups; (iii)
using an instrument in individual patients, as opposed to a
group of patients; and (iv) the use of instruments in clinical
practice. This paper reviews these issues, as well as current
attempts at resolving them. Illustrative examples are given.
It is concluded that solutions seem to be available, but
considerable research effort is required to make these a
reality. Clinimetrics in rehabilitation medicine remains
a ﬁeld with challenging opportunities for research.
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INTRODUCTION
Measurement in rehabilitation medicine concerns functioning
and disability: impairments of body structures and functions,
activity limitations and participation restrictions. Measurement
may also concern environmental and personal factors that
affect functioning and disability, but this article will focus on
measurement of functioning and disability. The measurement of
functioning and disability generally has 1 of 3 aims: diagnosis,
prognosis or evaluation (1). In diagnosis, the aim of measuring is
to discriminate between subjects. For example, in stroke patients
one may wish to discriminate between patients with good or
poor bladder function. In prognosis, the aim is to discriminate
between subjects on a longitudinal basis. One example is the
measurement of bladder function or other bodily functions at
admission in order to discriminate between stroke patients who
will or will not be able to live independently in 6 months time.
In evaluation, the aim of measurement is to evaluate changes
in functioning and disability over time. This may be illustrated
with the monitoring of walking ability, as an indicator of
progress during rehabilitation. A more complex example is a
clinical trial evaluating the differential change in walking ability
in groups of patients being treated with different exercise
regimens.
For these 3 purposes – diagnosis, prognosis and evaluation – a
wide range of measurement instruments is available. The
methodology for developing and evaluating these instruments
is becoming increasingly sophisticated. Traditional clinimetric
methods for evaluating reproducibility, validity and feasibility
(2) have been supplemented with methods to evaluate respon-
siveness (3) and interpretability (4), thereby extending the
evaluation of the quality of measurement instruments. Next to
classical test theory, item response theory has been introduced,
which offers new options in developing and using measurement
instruments. Furthermore, clinicians are increasingly inclined
to introduce measurement in clinical practice. Thus, the ﬁeld of
clinimetrics in rehabilitation medicine seems to be developing
rapidly.
Despite these encouraging developments, several issues have
not yet been resolved in a satisfactory way. These issues are
primarily related to the development and application of measure-
ment instruments. They include: (i) selection of an instrument
out of the wide range available; (ii) using an instrument in
diverse diagnostic groups; (iii) using an instrument in individual
patients, as opposed to a group of patients; (iv) the use of
instruments in clinical practice. The goal of the present article
is to summarize these issues and to present current ideas about
potential solutions.
SELECTION OF A MEASUREMENT
INSTRUMENT
Awide range of instruments is available to measure components
of functioning and disability. Even when focussing on a speciﬁc
aspect of functioning or a speciﬁc category of patients, one is
typically confronted with a disturbingly wide range of options.
In a way, the situation in measuring health resembles the
1Partly based on a lecture by Gustaaf Lankhorst at the Inter-
national symposium “Measurement and evaluation of outcomes in
rehabilitation”, September 2004.
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pre-Napoleonic era, when a variety of measures of length were
in use, thus creating confusion and impediments to trade. In the
ﬁeld of rheumatology, for example, more than 100 measures
of “patient outcomes” were identiﬁed (5); and this is clearly a
selection only, because neither biomedical nor biomechanical
nor work-related measures were included in this review. With
such high numbers of instruments available, the question of
how to select a measurement instrument becomes of paramount
importance. Because of the sheer number, it is not an easy task
to select the instrument that is best suited to a particular pur-
pose, even when one is aware of all the instruments available.
Furthermore, explicit and transparent criteria for selecting an
instrument should be available.
Systematic reviews of measurement instruments
A potential solution is to perform a systematic review of
measurement instruments. In a systematic review, one aims to
identify all measurements which are available for a speciﬁc
purpose, using systematic searches in electronic databases and
using explicit criteria to include or exclude instruments. This
procedure results in a set of selected instruments, which subse-
quently are described and evaluated. Descriptive information
on the instruments includes the goal of measurement, the nature
of the measurement instrument (e.g. questionnaire, rating of
performance, measurement of physical properties such as force
or pressure), the speciﬁc populations for which the instrument
was developed, the format of the measurement instrument
(e.g. number of items, response options, minimum and maxi-
mum score) and issues related to feasibility (e.g. time needed to
perform the measurement, required equipment and training).
In order to evaluate the selected instruments, information on
clinimetric properties is extracted from the studies identiﬁed
during the systematic search. Recently, a checklist has been
developed which facilitates the systematic evaluation of clini-
metric properties of measurement instruments (6, 7). This
checklist focuses on questionnaires and contains items on
validity, reproducibility, responsiveness, interpretability and
feasibility (practical burden). For illustrative purposes, some of
these items will be summarized here. For further information,
the reader is referred to the original publications (6, 7).
The concept of validity refers to the degree to which an
instrument measures what it is supposed to measure. The
checklist focuses on content and construct validity. Criterion
validity was not included in the checklist: a gold standard is
frequently not available in rehabilitation, which precludes
evaluation of criterion validity (i.e. the degree to which the
scores on an instrument correspond to the scores on the gold
standard). Content validity examines the extent to which
the domains of interest are comprehensively sampled by the
measurement instrument. In order to rate content validity,
the methods used for item selection and item reduction are
evaluated: because the questionnaires are supposed to address
disability as experienced by patients, a positive rating for
content validity is given when patients were involved in the
process of item selection and reduction. Construct validity refers
to the extent to which scores on a particular instrument relate to
other measures in a manner that is consistent with theoretically
derived hypotheses concerning the constructs that are being
measured. In the checklist, construct validity is considered to be
adequately tested if hypotheses were speciﬁed and the results
of the studies on construct validity correspond with these
hypotheses.
Reproducibility is the extent to which an instrument is free
of measurement error. The checklist focuses on test-retest
reliability and agreement. Reliability concerns the degree to
which patients can be distinguished from each other, using
a particular measurement instrument. Agreement concerns the
degree to which scores on repeated observations correspond
with each other. In the checklist, statistics and cut-off values
for reliability and agreement to be considered adequate are
deﬁned.
Responsiveness refers to an instrument’s ability to detect
important change over time in the concept being measured.
Responsiveness can be conceptualized as longitudinal validity:
does the instrument measure changes in the concept that it is
supposed to measure? Testing responsiveness is analogous to
testing construct validity: hypotheses on changes in the concept
being measured should be formulated and tested, using the
instrument being studied. In the checklist, responsiveness was
considered adequately tested if hypotheses were speciﬁed and
when the results were in correspondence with these hypotheses.
Concerning feasibility (practical burden), the checklist
focuses on time required for administration and ease of scoring.
In the checklist, criteria for ease of administration and ease
of scoring are provided.
Interpretability can be deﬁned as the degree to which one can
assign meaning to quantitative scores: information is required on
the clinical meaning of scores and on which difference between
scores can be regarded as clinically meaningful. In the checklist,
interpretability is rated positive if information is presented on
a minimal clinically important difference (MCID); or if infor-
mation is presented that could facilitate the interpretation of
scores (e.g. distribution of scores in subgroups of patients,
information on the relationship of scores to well-known func-
tional measures or clinical diagnoses, distribution of scores
before and after treatment).
Illustration of systematic review, using the checklist
The checklist was used in the evaluation of questionnaires on
shoulder disability (6). The systematic search and selection of
instruments resulted in 28 studies referring to 16 shoulder
disability questionnaires. Descriptive information and detailed
information on the clinimetric properties of these questionnaires
was provided, using the checklist. Furthermore, a table summa-
rizing the quality assessment was provided. From that summary
table, it was concluded that 1 speciﬁc questionnaire received
most positive ratings, i.e. overall, this questionnaire seems to
have the best clinimetric properties. This questionnaire was
the Disabilities of Arm, Shoulder and Hand Scale (DASH, 7).
However, as pointed out by the authors, the best scale is not
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always best for a particular purpose. For example, for the
evaluation of shoulder surgery, a questionnaire speciﬁcally
developed for shoulder surgery (8) may be preferred over the
DASH, which addresses shoulder disability in general instead
of speciﬁcally shoulder operations. Similarly, if one focuses
on diagnostic discrimination, a questionnaire with a particularly
high score for reliability (i.e. the Simple Shoulder Test, 9) may
be more appropriate than the DASH: the latter instrument seems
to be an all-purpose instrument, while the former might be more
appropriate if diagnostic discrimination is the primary and
overriding goal of measurement. Thus, in selecting an instru-
ment, one cannot simply select the instrument with the best
overall rating. Instead, in the context of a speciﬁc clinical or
research setting, one should select the instrument that is best
suited for the particular purpose in that speciﬁc context. The
process of selecting a measurement instrument starts with
clearly specifying the particular purpose of measurement. In
the next step, the information provided in the systematic review
may facilitate the selection process: the detailed and systematic
description of the instruments and their clinimetric properties
facilitates the choice of an instrument for use in a speciﬁc
setting.
Future developments
The checklist developed by Bot et al. (7) is by no means perfect.
However, based on previous checklists and current thinking
in clinimetrics, it seems to be the most up-to-date checklist
currently available. Further development of this or similar
checklists providing transparent and systematic criteria for
the evaluation of measurement instrument is clearly indicated.
Furthermore, the availability of the current or future checklists
may also improve the standards for reporting on clinimetric
studies. As pointed out by Bot et al. (7), the quality of reporting
on clinimetric studies is currently rather poor. Essential infor-
mation for the evaluation and selection of measurement instru-
ments was frequently found to be missing. Using the checklist,
future authors may improve the quality of their reports on
clinimetric studies.
Standardization of measurement
At present, only a few systematic reviews of measurement
instruments are available. It is our expectation that – similar to
the growth of systematic reviews of clinical trials, observational
studies and diagnostic research – more systematic reviews of
measurement instruments will become available in the near
future, thereby facilitating the selection of instruments from
the wide range of instruments described in the literature. The
ﬁndings in these reviews may also contribute to standardization
of measurement in rehabilitation. The current heterogeneity in
measurement instruments is an impediment for comparison and
synthesis of research ﬁndings in rehabilitation. The same applies
to clinical practice: communication about patients is hampered
by the diversity in measures used. Clearly, a certain degree of
standardization in measurement may facilitate communication
in rehabilitation medicine. The ﬁndings in systematic reviews
on measurement instruments may provide important input to the
process of standardization. Current attempts at deﬁning which
components of functioning and disability should be assessed in
various diagnostic categories (11) can be supplemented with the
results of systematic reviews on measurement instruments: once
consensus has been achieved on which dimensions are to be
assessed in a certain category of patients, one can than proceed
to a certain degree of standardization of measurement instru-
ments. The results of reviews on measurement instruments
based on transparent and systematically applied clinimetric
criteria provide essential input to this process.
Measurement always serves a speciﬁc purpose. The present
call for standardization is made within the general context of
acknowledging that a speciﬁc measurement instrument might
be appropriate for some purposes, but not for others. Thus, to
assess particular components of functioning and disability,
speciﬁc instruments are required. For example, a timed per-
formance test can be used to assess observed aspects of
walking ability, while a questionnaire is used to assess subjec-
tive walking ability. Furthermore, when assessing a particular
component of functioning and disability, the goal of measure-
ment may be diagnosis, prognosis or evaluation: the clinimetric
properties of the instrument might make it more suitable for one
of these goals, but not for another. For example, reproducibility
and validity are cardinal criteria for a diagnostic purpose, while
for the evaluation of treatment responsiveness is most important.
A certain degree of standardization of measurement instruments
is clearly indicated, but this should not obscure the fact that
speciﬁc instruments are required to fulﬁl speciﬁc measurement
purposes.
APPLYING MEASUREMENT INSTRUMENTS
IN VARIOUS DIAGNOSTIC
GROUPS: DIMENSIONALITY OF
MEASUREMENT INSTRUMENTS
Generic versus disease speciﬁc measures
Instruments can be categorized as either generic or speciﬁc
measures. Generic measures intend to measure the same con-
struct (activity limitations or participation restrictions) across
different patient groups, while speciﬁc measures are developed
for application in one diagnostic group only. The use of generic
measures has several advantages, including the reduced need
for developing and testing different instruments for all patients
groups separately, and uniformity of measurement in rehabili-
tation facilities (which is expected to facilitate communication
between rehabilitation professionals). An important advantage
is that, when using generic measures, the burden of different
diseases and disabilities can be compared among patient groups
and, in some cases, with the healthy population. Although it
is seems inevitable that the outcomes of generic measures
provide less speciﬁc information about each patient group, it is
also suggested that well-designed generic measures yield results
that are at least as good as disease speciﬁc instruments (2).
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Measurement instruments, whether generic or disease speci-
ﬁc, usually consist of 1 or more subscales (domains), where
items are summed to form a total subscale score. It is important
that the subscales measure 1 clearly deﬁned underlying con-
struct, such as mobility or communication, preferably based on
the domains of the International Classiﬁcation of Functioning,
Disability and Health (12). All items of the same (sub)scale are
supposed to measure 1 construct, and should therefore be related
to the construct that is intended to be measured. This implies
that all the individual items of the same subscale should be
moderately correlated with each other and that each item should
be correlated with the total scale score it belongs to and not (or
only weakly) to any other subscale (2).
Dimensional structure of measurement instruments
In rehabilitation medicine typically several patient groups with
varying disabilities and disease characteristics are treated, which
may explain the popularity of generic measures. However, prior
to applying generic measures in a variety of patient populations,
the clinimetric properties of generic measurement instruments
should be investigated in each patient group separately. Apart
from studying clinimetric properties, such as reproducibility and
interpretability, it is important to investigate the dimensional
structure of the instrument in each patient group separately.
In order to be able to calculate sum scores from the items, the
dimensions of the measurement instrument have to be consistent
across groups. It should therefore be tested whether the items
correlate with the same subscale scores (i.e. the dimensions they
belong to) in all patient groups. If items behave differently
(i.e. do not measure the supposed construct) it should be
reconsidered whether this item can be used in this patient group.
This is especially important in rehabilitation research because
pooled analyses are frequently performed, evaluating outcome
in a diagnostically mixed group of patients. Obviously, the
above also applies when using disease speciﬁc instruments in
other patient groups than that they have been developed for. It
may be possible that the same instrument can be used in other
patient populations, but this should be tested in advance.
Traditional methods to investigate the dimensional structure
of measurement instruments are factor analysis (or principal
component analysis) and determining internal consistency of
the dimensions (subscales) by calculating Cronbach’s alpha.
However, these methods have some recognized limitations
with the use of dichotomous and ordinal data (13). Another
approach that is increasingly applied in rehabilitation medicine
for investigating dimensional structure and scalability of
measurement scales is Rasch analysis.
The Rasch measurement model is based on item response
theory (14). It converts ordinal scales into an interval measure,
which expresses the difﬁculty of items and ability of the subjects
on 1 measurement continuum (logit or log odds unit, 14).
The Rasch model can be used to explore whether all items of the
scale measure a single construct (unidimensionality of a scale).
If items do not ﬁt the model, it indicates that these items do
measure a different construct. In general, Rasch analysis can
be applied for evaluating dimensions and scalability of newly
developed and existing instruments, but can also be used to
convert an ordinal scale into an interval measure for the
statistical analysis. Because item difﬁculties are expressed on
the same measurement continuum, Rasch analysis can also be
applied to investigate variations in item difﬁculties among
groups. The hierarchy of items, i.e. the location of the items
on the interval scale, is assumed to be invariant across groups.
Variation in item difﬁculty between groups is referred to as
differential item functioning (DIF). Different sources of DIF
can be identiﬁed, such as age, gender or culture. However,
disease can also be a source of DIF that should be taken into
account when comparing the outcomes of different patient
groups, or when pooling data in a (statistical) analysis. If
item difﬁculties vary between groups, identical sum scores
of different (patient) groups are likely to result from different
item proﬁles and thus different levels of functioning which,
again, hampers comparison between groups. This is a fairly
new ﬁeld of research and disease as a source of DIF has not yet
been fully investigated.
Findings in rehabilitation medicine
Examples of generic measures that are frequently used in
rehabilitation are the Barthel Index (BI), that measures physical
disability with 10 ordinal items, and the Functional Indepen-
dence Measure (FIM) for measuring disability in the motor
(13 items) and cognitive domain (5 items). The BI was originally
developed for patients with neuromuscular and musculoskeletal
disorders but has been used in several other diagnostics groups.
However, some studies showed that the BI is not always
suitable to measure physical functioning because of its lack of
unidimensionality (15, 16). The dimensional structure of the
FIM has been investigated extensively by several researchers
using a variety of methodologies. Results from factor analysis
showed that the 2-factor structure, that was proposed by Linacre
et al. (17), could be conﬁrmed in most patient groups, although
in some groups more than 2 dimensions could be distinguished
(18). However, other studies applying the more stringent Rasch
analysis showed however that the motor scale is not unidimen-
sional in all patient groups (19, 20).
In a recent Dutch study on functional prognosis in neuro-
logical disorders, results of different patient groups were pooled
to investigate shared determinants of functional outcome. In
order to be able to perform a pooled analysis of the different
patient groups involved in the study, DIF (among patient groups)
was investigated in several instruments using Rasch analysis.
Among others, the SF-36 Physical Functioning scale (10 items
on a 3-point rating scale) and the FIM were used to describe
the functional outcome in these patient groups. As an example,
results of the DIF analysis in patients with stroke, multiple
sclerosis and amyotrophic lateral sclerosis are shown in Fig. 1
(unpublished results).
In this ﬁgure the item difﬁculties (expressed in logits) are
shown for each group separately. It shows that the overall
hierarchy is comparable among groups, but that some item
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difﬁculties differ considerably. Comparison of item difﬁculties
among groups identiﬁed DIF in all group comparisons, but the
number of items showing DIF and the extent of DIF were rather
small. In Fig. 2 an example of a DIF plot is given, showing the
item difﬁculties for patients with stroke and MS. Three out of
the 10 items showed DIF. In contrast, results of the DIF analysis
performed on the FIM motor scale in patients with stroke, MS
and TBI showed less promising results; 7 out of 11 ﬁtting items
showed DIF.
Future developments
To perform a pooled analysis, or when comparing results among
patient groups, adjustments for DIF can be applied, as recently
described by Tennant et al. (21). Using this procedure, items
showing DIF are split up as disease speciﬁc items (see for
further explanation Tennant et al., 21). To what extent adjust-
ments for DIF among patient groups is required (or necessary)
in the different generic measurement instruments frequently
used in rehabilitation is, to our knowledge, not yet investigated.
It is, however, possible that DIF among patient groups causes
misﬁt of the data to the Rasch model. Other sources of DIF, such
as gender, age group or culture, should also be further explored
in future studies. Adjustment for DIF may lead to improvement
in measurement properties, such as improved discrimination
between groups and better responsiveness, but this also remains
to be investigated.
MEASUREMENT OF INDIVIDUAL PATIENTS
VERSUS A GROUP OF PATIENTS
Measurement in rehabilitation research typically concerns a
group of patients. An important reason for doing so is that
measurement error is reduced by taking the average of the
measurements in the group of patients: increasing the number
of observations reduces the error in the outcome of the
measurement. In clinical practice, however, one is interested in
measuring an individual patient: a measurement instrument may
be used to get an objective and quantitative value of impairments
of the body structures and functions, activity limitations and
participation restrictions in an individual patient.
Error of measurement
When measuring individual patients, the requirements for the
quality of the instruments used are higher than in the research
setting (22, 23). This is in contrast to common opinion in clinical
practice: clinicians tend to think that the quality requirements
for measurement in clinical practice are lower than in research
settings. However, taking the average of observations in a group
reduces the error of measurement; when measuring an indi-
vidual patient, one is confronted with the full, non-attenuated
error of measurement.
Thus, it has been frequently stated that the reliability co-
efﬁcient of instruments used in groups should be at least 0.70,
Fig. 2. Example of differential item functioning (DIF) plot for the
SF-36 Physical Functioning scale in patients with stroke and
multiple sclerosis (MS). Item difﬁculties for stroke are plotted on the
x-axis and for MS on the y-axis. An identity line is drawn through
the origin with a slope of 1. The area between the 2 other lines
indicates the 95% conﬁdence interval. Items outside this area
demonstrate DIF (unpublished results).
Fig. 1. Item difﬁculties (in logits) of the SF-36 Physical Functioning
scale for patients with stroke, multiple sclerosis (MS) and amyo-
trophic lateral sclerosis (ALS).
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while the reliability coefﬁcient of instruments used in individual
patients should be at least 0.90 (2, 13). Although the general
truth of this rule of thumb can be questioned, it is true that in
order to be reasonably certain that the score of an individual falls
within certain limits one needs a rather precise instrument with
little measurement error, i.e. the reliability of the instrument
should be relatively high. Conversely, if the clinician uses an
instrument that has adequate reliability in the group setting, he
should be aware of the fact that the measurement of individuals
is associated with a larger error. Because the reliability of many
existing instruments, although adequate in the group setting,
does not meet the high standards of the individual setting,
clinicians should be aware that measuring individual patients
is generally associated with a relatively high degree of error
and the results should be interpreted with some caution.
In addition to uncertainty about the actual measurement value
in a diagnostic or prognostic situation, measurement error limits
the ability to detect clinical change in a patient. When evaluating
change in an individual patient, real clinical change may be
obscured by measurement errors in the instrument used. An
instrument with a large error of measurement (i.e. with low
test-retest reliability) may fail to detect real clinical improve-
ment in an individual patient. The statement made above about
the need for a relatively high reliability when assessing
an individual patient applies also to the responsiveness of an
instrument, i.e. the ability of an instrument to detect clinical
change (3). When evaluating change in an individual patient,
the requirements about the responsiveness of the instrument
used are higher than in the group setting. Failure to demonstrate
improvement in an individual patient may be a true observation,
but it may also be the result of using an instrument which
responsiveness is not good enough to demonstrate change in
individual patients.
Adaptive or tailored testing
A potential solution for these problems is the development of
so-called adaptive or tailored testing, based on item response
theory (IRT, 2, 14). This approach consists of developing a
disability scale, comprising a large number of items (e.g. 200
items) which form a hierarchy: a hierarchy ranging from items
indicating a low level of disability to items indicating severe
disablement. If these items form a perfect hierarchy (as shown
by IRT-techniques), one can use a few items to screen for the
global level of disability; if the global level of disability is
known, one can then administer that part of the scale that
corresponds to the patient’s level of disability and thereby
determine the exact level of disability. For example, in a patient
who functions relatively well (as shown by the screening items),
one administers items from the low disability end of the scale;
for a patient in whom the screening items signal poor func-
tioning, one can administer items from the high disability end
of the scale. In determining the exact disability level, a rather
large but still feasible number of items (e.g. 30 items) can be
used: because one has to administer only items from the end
of the scale that corresponds to the level of disability of the
patients, all other items can be disregarded; the perfect hierarchy
of the scale ensures that the patient will or will not pass the
disregarded items. This large but feasible number of items
reduces measurement error and ensures precise measurement.
Theoretically, this approach of adaptive or tailored testing
offers the possibility to reduce measurement error considerably,
thereby allowing measurement with little error in individual
patients. Dijkers (24, 25) has demonstrated the value of adaptive
testing in simulation studies on the FIM, but the rather low
number of items in the FIM limits the value of adaptive
testing using the FIM. Thus, the actual value of this approach in
rehabilitation practice remains to be demonstrated.
Individualized measures
The trend towards patient-oriented rehabilitation has induced the
development of individualized measures (or patient-speciﬁc
measures). In patient-oriented rehabilitation, it is emphasized
that the patient has a strong say in deﬁning the problems that
should be addressed during rehabilitation. In this approach,
individualized measures are used, which are adapted to the
problems of a speciﬁc patient. In an individualized measure,
the patient deﬁnes the nature of the problem; and the patient
subsequently rates the severity of the problem. It is deemed
important that the patient describes the nature of the problem,
in his or her own words and in the context of his or her own daily
experiences. In clinimetric terms, this procedure is expected to
enhance the validity of the measurement of disability: by letting
the patient deﬁne the nature of the problem, one presumably
measures disability exactly as experienced by the patient. In
traditional instruments with standardized items (such as the
Sickness Impact Proﬁle or the SF 36), a selection of potential
problems is described, using common wordings; thus, there is
a risk that the patient’s speciﬁc problem is not mentioned
or the problem is described inadequately. Individualized
measures try to circumvent this, by letting the patient deﬁne the
problem.
Canadian Occupational Performance Measure
An example of an individualized measure is the Canadian
Occupational Performance Measure (COPM, 26). In a semi-
structured interview with an occupational therapist, the patient
identiﬁes problems in activities of self-care, productivity and
leisure. The patient then prioritizes these problems and selects
the 5 most important problems. The patient rates both per-
formance (i.e. ability to perform the activity) and satisfaction
(i.e. satisfaction with activity) of these problems on a 10-point
scale. The performance ratings are then added to a summary
score, as are the satisfaction ratings.
The divergent validity of the COPM was studied (26).
Divergent validity refers to the ability of an instrument to
differentiate the concept under study from other constructs.
In support of the divergent validity of the COPM, it was found
that for 81 problems out of 443 problems identiﬁed with the
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COPM, no corresponding item could be found in 2 traditional
instruments (i.e. the SIP68 and the Disability Impact Scale
(DIP)). Examples included problems with sitting, caring for
loved ones such as grandchildren and spouse, and personal
appearance. Furthermore, correlations between scores on the
COPM and the SIP were low. Thus, there is some support for
the hypothesis that the COPM, as an individualized measure,
assesses problems that are not assessed with traditional
instruments.
Not completely unexpected, it was found that the repro-
ducibility of the COPM left something to be desired (unpub-
lished data). Patients were assessed twice, with an interval of
7 days, by 2 different therapists. Only about two-thirds of
the problems prioritized by the patients at the ﬁrst assessment
were also prioritized at the second assessment. Furthermore,
the reproducibility (intraclass correlation coefﬁcient) of the
performance score was moderate; the same applied to the
satisfaction score. Thus, it seems that there is a risk that in a
individualized measure like the COPM, the lack of standardized
items leads to a reduced reproducibility of the measurement
results. The semi-structured interview and the process of prior-
itizing problems leave room for considerable variation (error)
among patients and among test occasions.
As expected, the responsiveness of the COPM appeared to be
rather good (unpublished data). Patients were assessed before
and after occupational therapy. The COPM was sensitive in
detecting improvement as reported by patients on a transition
index (criterion responsiveness). In addition, improvement on
the COPM correlated with improvement on other measures such
as the Sickness Impact Proﬁle (construct responsiveness).
These results suggest that the COPM, as an individualized
instrument, indeed measures aspects of patients’ problems
which are not assessed by traditional instruments consisting
of standardized items. Similarly, it seems that having patients
deﬁne the nature of the problem indeed results in a responsive
measure. However, probably as a result of the individualized
nature of this instrument, the COPM is not the best instrument
for the purpose of comparing patients and distinguishing among
patients (reliability).
USING MEASUREMENT INSTRUMENTS
IN CLINICAL PRACTICE
Increasingly, clinicians are inclined to use measurement
instruments in clinical practice. This may be due to an intrinsic
interest in measurement, which yields a quantitative estimate
of impairments of the body structures and functions, activity
limitations and participation restrictions. On the other hand,
clinicians are under extrinsic pressure from the management
of their institute to introduce measurement in clinical practice,
especially to evaluate rehabilitation outcome. Given the in-
creasing use of measurement in clinical practice, be it intrinsi-
cally or extrinsically motivated, a critical appraisal of this trend
seems to be in place.
Clinical assessment versus measurement in research projects
Clinical assessment of a patient in rehabilitation medicine
is different from measurement for research applications. In
clinical rehabilitation we are dealing with patients with perma-
nent disabilities as a result of disease or injury. Clinical
assessment aims at identifying problems and potential solutions.
It does not necessarily include measurement. The purpose of
clinical assessment of a patient is to identify his/her activity
limitations and restrictions in participation, to identify impair-
ments that underlie the activity limitations and to ﬁnd options
for treatment of these conditional impairments. This is typically
done by history taking, including a checklist of activities and
participation and by physical examination, sometimes supple-
mented with additional examinations (X-ray, gait analysis). On
the basis of this assessment a rehabilitation diagnosis is made,
rehabilitation goals are deﬁned and a rehabilitation program is
designed (what is desirable? what is possible?).
Trying to combine measurement and clinical assessment
is not always easy. The Rehabilitation Activities Proﬁle is a
clinical assessment tool (RAP, 27) with the domains: Commu-
nication, Mobility, Personal care, Occupation and Relationships.
It can be used as a checklist with or without a 0–3-point severity
rating. Using the quantitative version turned out to be rather
time-consuming and did not increase satisfaction in RAP-teams
(28). The qualitative version, however, is widely used in The
Netherlands. On the other hand, Wikander et al. (29) have
reported the successful use of the FIM for both team commu-
nication and assessment/evaluation. In a randomized controlled
trial patients in the FIM group more patients regained continence
before discharge than in the control group. There was also a
greater improvement in well being in the FIM group.
Outcomes measurement
Outcomes measurement came up during the 1980s as a result
of increasing healthcare costs, although it was also expected to
improve quality of care and patient outcome (30). The challenge
was accepted by the US rehabilitation community, which
resulted in the development of the Functional Independence
Measure (FIM). The FIM was soon used in many rehabilitation
facilities in the US and Europe. Traditional clinimetric proper-
ties (e.g. reliability) are reported to be good (31).
What is certainly important in this respect about FIM are its
instruction and certiﬁcation courses. However, even trained
FIM users have been found to be biased in their judgement
of FIM items, when they had knowledge of scores of other
team members on other items (32). An important question
regarding outcomes research is whether patients have any
beneﬁt from the use of outcome measures on a routine basis in
clinical practice. When the data are being gathered and used
as part of a quality of care system, this is probably the case.
However, rehabilitation teams are often under pressure to do
outcome measurements as part of “best practice”. There seems
to be no good reason to do that, because the time used
for measurement might be at the expense of treatment
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time. Outcome measurement is sometimes recommended to
improve accountability of rehabilitation providers. Here caution
should be applied. Clinicians might be tempted to change their
case mix rather than improving the quality of rehabilitation care,
in order to meet demands about outcome performance.
Thus, the trend towards increased use of measurement
instruments in clinical practice should be seen with some
reservation. Clinical assessment of a patient in rehabilitation
medicine involves much more than the mere application of
measurement instruments and it might not always be wise to
combine measurement and clinical assessment. The use of
outcome measures in clinical practice only for management
purposes is not to be recommended: outcome measures
should ideally be used in the context of improvement of quality
of care.
CONCLUSION
It has been argued that, despite promising developments, several
issues concerning the development and application of measure-
ment instruments in rehabilitation medicine remain to be re-
solved. This paper describes and illustrates these issues, as well
as current attempts at solving these issues. (i) In several ﬁelds
of research, the range of instruments available is disturbingly
wide: systematic reviews of measurement instruments may
facilitate the selection of an adequate instrument from all
instruments available. Furthermore, a certain degree of stan-
dardization may facilitate both synthesis of results in research
and communication in clinical practice. (ii) Application of an
instrument in a variety of diagnostic groups requires that the
dimensional structure of the instrument and the difﬁculty of
separate items is comparable across these diagnostic groups.
Statistical techniques, including factor analysis and Rasch
analysis, are available to test this. If item difﬁculty varies
substantially among diagnostic groups, statistical corrections
are possible, but it remains to be demonstrated that these
procedures indeed improve the quality of the measurement
instrument. (iii) When measuring individual patients (as
opposed to a group of patients), one is confronted with a rela-
tively high measurement error. A potential solution is to use
highly reliable instruments (i.e. instrument with little measure-
ment error): in rehabilitation medicine, these instruments are
not frequently available, however. Another solution could be
so-called adaptive or tailored testing. This kind of instrument
still has to be developed in rehabilitation medicine. When
measuring individual patients, individualized or patient speciﬁc
measures can be used. The validity and responsiveness of such
a measure seem to be rather high, but this seems to be achieved
at the expense of a relatively low reliability. (iv) A critical
appraisal of the introduction of measurement in clinical practice
seems to be indicated. Clinical assessment of a patient is
not equivalent to applying measurement instruments: clinical
assessment may or may not include measurement. The use
of outcome measures only for management purposes is
not to be recommended: in clinical practice, outcome measures
are ideally used in the context of improvement of quality
of care.
In summary, in the development and application of measure-
ment instruments in rehabilitation medicine several issues
remain to be solved. It is concluded that solutions for these
issues seem to be available, but considerable research effort is
required to make these potential solutions a reality. Clinimetrics
in rehabilitation medicine remains a ﬁeld with challenging
opportunities for research.
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